“Pharma Cos Need To Improve Mfg Standards”
  • Prabha Hedge
  • Nov 28 2013

November 28: “Manufacturing violations have been rampant across various domestic and international pharma companies,” says, Vikas Dandekar, India Bureau Chief, Elsevier Business Intelligence, PharmaAsia News.